Literature DB >> 1273518

A Clq immunosorbent assay compared with thin-layer gel filtration for measuring IgG aggregates.

S Ahlstedt, L A Hanson, C Wadsworth.   

Abstract

A new sensitive technique measures C1q-binding of human IgG aggregates. The method is based on the principle of the enzyme-linked immunosorbent assay with C1q-coated tubes. The IgG aggregates attaching to this C1q are shown by enzyme-linked anti-human IgG. Less than 0.01 mug of aggregates per milliliter of sample can be detected. The results with this new method showed significant correlation (P less than 0.01; Spearman rank correlation test) with the estimates of IgG aggregates of 13S or more and 10S in size obtained by thin-layer gel filtration. Both of these methods showed significant correlation with the classic hemolysis inhibition method for measuring complement fixation.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1273518     DOI: 10.1111/j.1365-3083.1976.tb00281.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  11 in total

1.  Some characteristics of aggregates of IgG and plasma proteins in heat-treated factor VIII concentrates.

Authors:  C Wadsworth; L A Hanson; H Kjellman; T Söderström; M Blombäck
Journal:  Blut       Date:  1989-03

2.  Studies on circulating soluble immune complexes of the liver disease. 1. Inhibition assay of polyclonal rheumatoid factor binding to IgG-sepharose.

Authors:  J Narumoto; T Arima; K Kunishi; T Yasuhara; K Suwaki; H Shimomura; H Nagashima
Journal:  Gastroenterol Jpn       Date:  1979-12

Review 3.  Immune complexes in human diseases: a review.

Authors:  A N Theofilopoulos; F J Dixon
Journal:  Am J Pathol       Date:  1980-08       Impact factor: 4.307

4.  Inhibition of direct binding of enzyme-conjugated antihuman IgG t C1q using dextran sulphate in solid phase assays for immune complexes.

Authors:  M Gripenberg; M Rhen; A Hautanen; E Linder
Journal:  J Clin Pathol       Date:  1982-05       Impact factor: 3.411

5.  Failure to detect immune complexes in the secondary stage of pityriasis rosea.

Authors:  H Mobacken; L M Bjursten; G B Löwhagen; L A Nilsson
Journal:  Arch Dermatol Res       Date:  1983       Impact factor: 3.017

Review 6.  Enzyme immunoassays with special reference to ELISA techniques.

Authors:  A Voller; A Bartlett; D E Bidwell
Journal:  J Clin Pathol       Date:  1978-06       Impact factor: 3.411

7.  Studies on circulating soluble immune complexes of the liver disease. 6. Comparative studies of 125I-pRF inhibition assay, 125I-Clq inhibition assay and 125I-Clq binding assay.

Authors:  J Narumoto
Journal:  Gastroenterol Jpn       Date:  1981

8.  Evaluation of serum rosette inhibitory factors in chronic liver disease.

Authors:  D Zauli; F B Bianchi; M Fusconi; C Crespi; E Pisi
Journal:  Clin Exp Immunol       Date:  1983-07       Impact factor: 4.330

9.  Studies on circulating immune complexes of the liver disease. 4. Clq binding activity.

Authors:  T Arima; J Narumoto; H Shimomura; K Suwaki; K Kunishi; T Yasuhara; H Nagashima
Journal:  Gastroenterol Jpn       Date:  1980

10.  Studies on circulating immune complexes of the liver disease. 3. Conditions for Clq binding assay and low molecular weight Clq reactants.

Authors:  T Arima; J Narumoto; H Shimomura; K Suwaki; K Kunishi; T Yasuhara; H Nagashima
Journal:  Gastroenterol Jpn       Date:  1980
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.